Journal of Cystic Fibrosis, 14(2), 203-210
A method for preventing drug-induced ototoxicity in an individual in need thereof comprising intratympanic administration of a pharmaceutical composition comprising a therapeutic agent, wherein the therapeutic agent is an antioxidant or anti-apoptotic agent, wherein the pharmaceutical composition is administered prior to onset of therapy with the drug, and wherein the composition provides sustained release of the therapeutic agent into the ear for a period of at least 5 days after a single administration
Effect of Gly-Gly-His, Gly-His-Lys and their copper complexes on TNF-alpha-dependent IL-6 Secretion in normal human dermal fibroblasts
52 These results, in part, supported the development of orforglipron as an orally delivered GLP-1RA in clinical testing
Gunjal A, Patwardhan R, Jedhe A, Choudhary V (2022) Plasmid-curing, antimicrobial, antioxidant properties and phytochemical analysis of medicinal plants from North East India.(2021)
Comprehensive phenotyping of T cells using flow cytometry
